by Charles Ornstein, ProPublica
This story was co-published with NPR’s Shots blog.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
by Charles Ornstein, ProPublica
This story was co-published with NPR’s Shots blog.
Medicare’s Sunshine Act database is slated to go public later this month with a year’s worth of data on industry relationships with physicians, but an alliance of life sciences groups is calling for some sunshine of its own.
As with previous years, it’s time to openly publish my conflict of interests, board memberships, advisory board positions, and government activities so that anyone reading my opinions has full transparency.
The federal government has made financial disclosure very easy with the Sunshine Act.
by Charles Ornstein, ProPublica
by Charles Ornstein, ProPublica
Next month, when the federal government releases data about payments to physicians from pharmaceutical and medical device makers, one-third of the records will be withheld because of data inconsistencies, an official told ProPublica.
MASSDEVICE ON CALL — Physicians’ groups are up in arms about the looming launch of the a public database of industry-doctor relationships, citing concerns about errors in reporting and security breaches that appear to muddle the program’s credibility.
The public database, scheduled to go live September 30, will allow anyone with interest to peruse troves of data about the financial exchanges between doctors and manufacturers of drugs and medical devices, but the novel program has its share of issues.
A massive alliance of medical societies urged Medicare regulators this week to keep physician pay data from the public for an extra 6 months, time that doctors can use to peruse their profiles for inaccuracies about their financial relationships with medical device and drug companies.
The proposal would keep physician financial data under wraps until March 31, 2015, rather than Sept. 30, 2014, as planned.
Medicare regulators are looking for feedback on proposed changes to the laws governing transparency in financial relationships between doctors and healthcare companies, warning that the changes may represent a hefty new cost for medical device makers in particular.
by Charles Ornstein, ProPublica
The federal government has a word for physicians who don’t have financial relationships with pharmaceutical and medical device manufacturers: "Error."